Featured Research

from universities, journals, and other organizations

Patients at risk for complications after coronary artery fistula closure

Date:
March 24, 2010
Source:
American Heart Association
Summary:
After surgery to repair abnormally connected heart arteries called coronary artery fistula (CAF) some patients fare worse than others. This study suggests that CAF that drain into the coronary sinus (at the back of the heart) are more likely to have complications after corrective surgery.

Long-term complications after procedures to close coronary artery fistulas are particularly prevalent among those whose abnormal connections to the heart result in drainage into the coronary sinus, according to a study published in Circulation: Cardiovascular Interventions, a journal of the American Heart Association.

Related Articles


A coronary artery fistula is an abnormal connection between a coronary artery and a chamber of the heart or vessel. The coronary sinus is the end portion of a large vein at the back of the heart that receives blood from the heart's veins and empties into the right atrium.

The study found that procedures to close a CAF were associated with increased long-term risks of angina, coronary thrombosis (a clot in one of the heart's blood vessels), heart failure and heart attack.

To determine which patients are most at risk for these complications after closure, researchers reviewed the medical records of 76 patients diagnosed with congenital coronary artery fistula. Sixty-four patients underwent transcatheter closure or surgical repair of the fistula.

The researchers found that 15 percent of patients had major complications following closure, including heart attack, angina with coronary thrombosis, or symptomatic cardiomyopathy (heart failure). The only angiographic finding associated with major complications was drainage of the coronary artery fistula into the coronary sinus.

Other predictors associated with adverse outcomes included older age at diagnosis, tobacco use, diabetes, hypertension and hyperlipidemia (or high cholesterol).

Physicians should consider reducing atherosclerotic risk factors and long-term use of blood thinning medications after coronary artery fistula closure, especially for patients with fistula that drain into the coronary sinus, the researchers said.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Patients at risk for complications after coronary artery fistula closure." ScienceDaily. ScienceDaily, 24 March 2010. <www.sciencedaily.com/releases/2010/03/100323161501.htm>.
American Heart Association. (2010, March 24). Patients at risk for complications after coronary artery fistula closure. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2010/03/100323161501.htm
American Heart Association. "Patients at risk for complications after coronary artery fistula closure." ScienceDaily. www.sciencedaily.com/releases/2010/03/100323161501.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins